SCHEMBL14780384

SCHEMBL14780384

Cc1ccc(S(=O)(=O)Cc2cc(Br)ncc2[N+](=O)[O-])cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.60
MEN1 O00255 5/20 0.60
RAB9A P51151 2/20 0.60
MAPT P10636 3/20 0.50
HPGD P15428 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ATM Q13315 1/20 0.44
ALDH1A1 P00352 3/20 0.43
POLB P06746 1/20 0.42
PAX8 Q06710 1/20 0.41
TXNRD1 Q16881 1/20 0.41
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
HSP90AA1 P07900 1/20 0.39
CXCR5 P32302 1/20 0.39
APLNR P35414 1/20 0.39
CCR6 P51684 1/20 0.39
GFER P55789 1/20 0.39
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15173646 0.76 SMN1; SMN2 (0.41) MAPTALDH1A1POLBGAAHTT
SCHEMBL31260000 0.74 KMT2A (0.49) KMT2AMEN1RAB9AMAPTHPGD
SCHEMBL14780140 0.74 KMT2A (0.49) KMT2AMEN1RAB9AMAPTHPGD
SCHEMBL5738819 0.74 KMT2A (0.62) KMT2AMEN1RAB9AMAPTATM
SCHEMBL4481965 0.73 KMT2A (0.52) KMT2AMEN1RAB9AMAPTHPGD
SCHEMBL3378024 0.72 KMT2A (0.53) KMT2AMEN1RAB9AMAPTHPGD
SCHEMBL24681086 0.71 SNCA (0.37) KMT2AMEN1MAPTALDH1A1GAA
SCHEMBL28114429 0.69 PAX8 (0.60) KMT2AMEN1RAB9AMAPTHPGD
SCHEMBL2107234 0.69 ALDH1A1 (0.49) KMT2AMEN1MAPTALDH1A1GAA
SCHEMBL29709755 0.69 ALDH1A1 (0.49) KMT2AMEN1MAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3653618-B1 NEW DIHYDROQUINOLINE-2-ONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2025-01-08 EP disclosed
EP-3653618-A1 NEW DIHYDROQUINOLINE-2-ONE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2020-05-20 EP disclosed
EP-2755963-B1 NEW DIHYDROQUINOLINE-2-ONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2019-10-30 EP disclosed
CN-103814021-B Dihydroquinoline 2 ketone derivatives 霍夫曼-拉罗奇有限公司 2016-12-21 CN disclosed
US-9260408-B2 Dihydroquinoline-2-one derivatives HOFFMANN-LA ROCHE INC. (US) 2016-02-16 US disclosed
US-9260408-B2 Dihydroquinoline-2-one derivatives HOFFMANN-LA ROCHE INC. (US) 2016-02-16 US disclosed
EP-2755963-A1 NEW DIHYDROQUINOLINE-2-ONE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2014-07-23 EP disclosed
WO-2013037779-A1 NEW DIHYDROQUINOLINE-2-ONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-03-21 WO disclosed
US-20130072679-A1 DIHYDROQUINOLINE-2-ONE DERIVATIVES CINCOR PHARMA, INC. 2013-03-21 US disclosed
US-20130072679-A1 DIHYDROQUINOLINE-2-ONE DERIVATIVES CINCOR PHARMA, INC. 2013-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130072679-A1 DIHYDROQUINOLINE-2-ONE DERIVATIVES CYP11B1, CYP11B2, HSD11B1 KMT2A 2848/4885MEN1 373/4885RAB9A 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.